BTIG lowered the firm’s price target on Hims & Hers to $60 from $85 and keeps a Buy rating on the shares as part of a broader research note previewing Q4 for Healthcare IT and Digital Health names.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims and Hers Health call volume above normal and directionally bullish
- Option traders moderately bearish in Hims and Hers Health with shares down 2.63%
- Mixed options sentiment in Hims and Hers Health with shares down 0.67%
- UAA, MARA, HIMS: The 10 Most Shorted Stocks in the Market
- Bullish flow in Hims and Hers Health with shares up 0.41%